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Abstract p67phox and p47phox are phosphorylated in the course
of stimulation of the NADPH oxidase in neutrophils. Isolated
neutrophil cytosol can phosphorylate both of these proteins in
vitro. Phosphoamino acid analysis showed that isolated mem-
branes can tyrosine-phosphorylate p67phox in vitro. Further
experiments with anti-phosphotyrosine antibodies did not support
a role for tyrosine phosphorylation of p67phox in the cell. A
phosphopeptide analysis showed that the phosphorylation of
p67phox is unchanged in the absence of p47phox. These results
further characterise the phosphorylation of p67phox and provide
evidence that this is a cytosolic event independent of interaction
with p47phox and the membrane.
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1. Introduction
p67phox is a component of the nicotinamide adenine dinu-
cleotide phosphate, reduced form (NADPH) oxidase, the mul-
ticomponent enzyme that causes the production of superoxide
in phagocytes. It is one of the components that is located
predominantly in the cytosol and a small proportion trans-
locates to the membrane upon activation of the neutrophil.
For p67phox, p47phox, p40phox and Rac, the translocation has
been estimated in the range of 2^20% of each protein [1]. The
higher values averaging 10^15% occur with stimulation by
phorbol ester, whereas only 2^5% translocates with receptor-
mediated stimulation [2,3]. The formation of an active
NADPH oxidase at the membrane is dependent on these com-
ponents, as evident by £avocytochrome-positive autosomal
chronic granulomatous disease (CGD), which is caused by a
de¢ciency of either p67phox or p47phox.
In addition to translocation, the phox proteins become
phosphorylated upon stimulation of the NADPH oxidase.
There is growing proof that phosphorylation plays an essen-
tial role in the activation process. In addition to temporal
correlation between the phosphorylation events and the acti-
vation of the NADPH oxidase [4^6], the requirement of phos-
phorylation sites in p47phox is supported by the e¡ect of muta-
genesis of p47phox on the translocation and activity in
transfected cell systems [7^9]. The phosphorylation of several
residues in p47phox takes place in the cytosol [10] and more
phosphorylation occurs after translocation to the £avocyto-
chrome at the membrane [11,12]. It is believed that phospho-
rylation confers activation by causing conformational changes
which lead to certain interactions between the components.
Experimental evidence for this comes from spectroscopic
measurements of alterations in the p47phox conformation
[13,14], protein-protein interaction studies [15,16] and the
phosphorylation-dependent activation of cell-free oxidase sys-
tems [13,17].
Unlike the phosphorylation of p47phox which was the ¢rst
biochemical abnormality identi¢ed in autosomal CGD [18,19],
the phosphorylation of p67phox has been less intensively inves-
tigated. We have recently reported that the major site of phos-
phorylation is the single amino acid threonine-233 [20], which
contrasts with the multiple site phosphorylation of the C-ter-
minus of p47phox [21]. The phosphorylation of threonine-233
can be brought about in vitro by isolated cytosol or mitogen-
activated protein kinase [20]. However, as with the other phox
components, the exact dynamics of the events of phosphoryl-
ation, intercomponent interactions and translocation to the
membrane remain to be deciphered for p67phox. Here, we fur-
ther investigate the phosphorylation of p67phox, ¢nding evi-
dence for the reaction taking place in the cytosol by a mech-
anism independent of any interaction with p47phox or the
membrane.
2. Materials and methods
2.1. Cell preparation and fractionation
Neutrophils were prepared [22] from bu¡y coats or freshly drawn
heparinised blood, from healthy volunteers. The media used when
labelling neutrophils was phosphate-free HEPES-bu¡ered saline
(HBS) (20 mM HEPES, 137 mM NaCl, 2.7 mM KCl, 1 mM MgSO4,
1 mM CaCl2, pH 7.4). Neutrophils were resuspended at 5U107/ml in
HBS/glucose/bovine serum albumin (0.025%(w/v)) and incubated with
32Pi at 0.1^0.5 mCi/ml, 30‡C, 60 min. For the study of CGD cells,
EBV-transformed B-cells from normal subjects and p47phox de¢cient
patients were grown in culture and incubated at 1U107/ml in phos-
phate-free RPMI with 10%(v/v) dialysed foetal bovine serum and 32Pi
at 0.1^0.5 mCi/ml, 37‡C, 4 h. Stimulation of cells by serum-opsonised
zymosan (SOZ, 1 mg/ml, 7 min) or 12-phorbol myristate 13-acetate
(PMA, 1 Wg/ml, 5 min) or N-formyl-methionyl-leucyl-phenylalanine
(fMLP, 1 WM, 1 min) following a pre-incubation of the cells with
cytochalasin B (5 Wg/ml, 5 min) was quenched by the addition of a
more than ¢ve times volume excess of ice-cold media. Cells were
sedimented by centrifugation at 200Ug, 4‡C, 3 min, then lysed by
sonication in relaxation bu¡er (10 mM Pipes, 3 mM NaCl, 100 mM
KCl, 3.5 mM MgCl2, 1.25 mM EGTA, pH 7.3). Protease and phos-
phatase inhibitors were present during sonication and subsequent pro-
cedures (1 mM diisopropyl £uorophosphate, 0.2 mM phenylmethyl-
sulphonyl £uoride, 10 Wg/ml N-K-p-tosyl-L-lysine chloromethyl ketone,
10 Wg/ml leupeptin, 10 Wg/ml pepstatin, 1 mM benzamidine, 20 mM
NaF, 5 mM sodium pyrophosphate, 200 WM NaVO4, 100 nM micro-
cystin). Cytosol was prepared by centrifuging the lysate at 500Ug,
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4‡C, 5 min, followed by 100 000Ug, 4‡C, 12 min. Membranes were
prepared by centrifuging the cell lysate at 150 000Ug, 4‡C, 30 min,
through a discontinuous sucrose gradient and collecting the interface
between layers of 15% and 34% (w/v) sucrose.
2.2. Immunoprecipitation experiments
Immunoprecipitations were carried out in solubilisation bu¡er
(20 mM Tris, 150 mM NaCl, 1% (v/v) Triton X-100, 1% (w/v) sodium
deoxycholate, 0.1% (w/v) SDS, pH 7.3), as published previously [20].
Brie£y, the cellular fraction was pre-adsorbed against protein-A
sepharose to reduce the non-speci¢c binding and then incubated
with an a⁄nity-puri¢ed antibody raised in rabbits against either
full-length GST-p67phox or GST-p47phox fusion protein. Immunocom-
plexes were sedimented after incubation with protein-A sepharose.
After washing, the immunoprecipitate was boiled in Laemmli sample
bu¡er and subjected to SDS-PAGE. The bands from Coomassie blue
staining and autoradiography were quanti¢ed using a Fuji BAS1000
PhosphorImager or an Alpha Innotech AlphaImager 2000.
2.3. In vitro phosphorylation
25 Wl reactions were set up on ice consisting of 5 Wl 5Ukinase bu¡er
(50 mM MgCl2, 2.5 mM CaCl2, 100 mM HEPES, pH 7.4), 5 Wl
0.5 mM ATP at approximately 1000 cpm/pmol, 0.5^5 Wg recombinant
p67phox or p47phox protein) and kinase in the form of cytosol
(1^5U104 cell equivalent (eq)) or membranes (1^3U106 cell eq). Fol-
lowing an incubation of 30‡C, 20 min, the reactions were stopped by
the addition of 3 Wl 10ULaemmli sample bu¡er, then boiled and
subjected to SDS-PAGE.
2.4. Phosphopeptide mapping
Phosphorylated p67phox, either from an immunoprecipitate or an in
vitro phosphorylation reaction, was excised from a SDS-PAGE gel
and subjected to tryptic digestion as previously described [20]. A CBS
Scienti¢c Hunter Thin Layer Electrophoresis 7000 system was used
for 2D phosphopeptide mapping and images were obtained with a
Fuji BAS 1000 PhosphorImager. The ¢rst dimension of resolution
was by electrophoresis in pH 1.9 bu¡er (2.5% (v/v) formic acid,
7.8% (v/v) acetic acid), 1000 V, 35 min and the second dimension
was by thin layer chromatography in Phospho-chromatography bu¡er
(7.5% (v/v) acetic acid, 25% (v/v) pyridine, 37.5% (v/v) butanol), 6^8 h.
For phosphoamino acid analysis, consecutive electrophoresis steps of
1500 V, 20 min, pH 1.9 bu¡er and 1300 V, 16 min, pH 3.5 bu¡er
(0.5% (v/v) pyridine, 5% (v/v) acetic acid) were carried out. Phospho-
amino acid markers were detected by ninhydrin spray (0.25%(w/v) in
acetone) and their positions were outlined on the phosphorimage.
2.5. Phosphotyrosine immunoblotting
SDS-PAGE gels were blotted onto nitrocellulose using a LKB 2117
Multiphor semidry electroblotter. The anti-phosphotyrosine antibody
was the recombinant RC20:HRPO from Transduction Laboratories.
This antibody is conjugated with horse radish peroxidase eliminating
secondary antibody incubations. Incubations were carried out follow-
ing the manufacturer’s instructions, including using BSA blocking
solutions without milk powder and detection by the enhanced chem-
iluminescence method.
3. Results and discussion
Previous studies have established that phosphorylated
p67phox and p47phox are present in the cytosol of neutrophils
after stimulation of the NADPH oxidase [5,20,23^25]. In or-
der to directly compare the increase in the phosphorylation of
p67phox upon stimulation of neutrophils with that of p47phox,
immunoprecipitations of p67phox and p47phox were carried out
in parallel on cytosol from 32P-radiolabelled cells. The relative
phosphorylation was quanti¢ed by measuring the ratio of the
immunoprecipitated radioactivity to the amount of immuno-
precipitated protein for p67phox and p47phox separately (Fig.
1). Some phosphorylation of both p67phox and p47phox was
evident in the neutrophils which were not exposed to an ago-
nist of the NADPH oxidase (‘unstimulated’). This could in-
dicate either a physiological basal level of phosphorylation in
resting neutrophils or that the cells received some stimulation
as a result of handling during the experiment. An increase in
phosphorylation was observed in the conditions of NADPH
oxidase activation for both proteins, but was much higher for
p47phox than for p67phox. This is consistent with there being
one major phosphorylation site in p67phox [20] and multiple
sites in p47phox [21].
Upon incubation of the cells with SOZ, the level of phos-
phorylation increased by a factor of 2.17 þ 0.52 and
4.97 þ 2.50 for p67phox and p47phox, respectively. The magni-
tude of phosphorylation was signi¢cantly higher using the
phorbol ester agonist, PMA, with increases of 3.24 þ 1.14
and 26.77 þ 10.12 for p67phox and p47phox, respectively. As a
particulate agonist that causes phagocytosis, SOZ is likely to
represent a more physiological stimulation of the NADPH
oxidase in the neutrophil than PMA. The phosphorylation
state of p67phox has been shown to be the same by SOZ and
PMA stimulation [20], therefore the higher phosphorylation
by PMA must represent more molecules of phosphorylated
p67phox. The phosphorylation sites of p47phox by particulate
stimulation have not been mapped. The disproportionate in-
crease in the phosphorylation of p47phox by PMA stimulation,
approximately eight times that of SOZ stimulation, is likely to
be caused by the direct activation of PKC for which there are
several candidate sites in p47phox [26].
In vitro phosphorylation of recombinant p67phox and
p47phox can be achieved using cytosol isolated from neutro-
phils. Not surprisingly, p47phox becomes more heavily phos-
phorylated than p67phox (Fig. 2). However, the di¡erence in
Fig. 1. Comparison of the p67phox and p47phox phosphorylation in
neutrophils. (A) Immunoprecipitates of p67phox or p47phox from
4.5U107 cell eq cytosol of radiolabelled neutrophils were subjected
to SDS-PAGE, then Coomassie-stained (gels) and exposed to ¢lm
for 2 weeks (autorads). Neutrophils were either unstimulated or
stimulated with 1 mg/ml SOZ for 5 min or 1 Wg/ml PMA for 6 min,
prior to lysis and immunoprecipitation. (B) Quantitation of the in-
crease in the phosphorylation upon activation relative to unstimu-
lated cells, from four experiments, error bars indicate S.D. Values
were derived from band densitometry of the autorad signal and
were corrected for the amount of protein detected by Coomassie
staining.
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the magnitude of phosphorylation cannot be accounted for
solely by the higher number of phosphorylation sites in
p47phox. That is, there is a greater di¡erence between the
phosphorylation of p67phox and p47phox in the in vitro experi-
ment than that observed in the immunoprecipitations. This
suggested to us that p67phox may require a co-factor to
achieve the maximal phosphorylation. The addition of either
the small G-protein Rac or p40phox did not enhance the phos-
phorylation of p67phox in vitro. Neither did the activation
state of the cytosol have an e¡ect, as the same level of phos-
phorylation was achieved using cytosol isolated from unstimu-
lated and stimulated neutrophils (LV Forbes, data not
shown).
To investigate whether the phosphorylation of p67phox
could involve an interaction with the membrane, the cytosol
in the in vitro experiment was replaced by the membranes
fraction of the neutrophil lysate. Phosphoamino acid analysis
of membrane-phosphorylated p67phox showed that phospho-
rylation occurred on tyrosine residues (Fig. 3A), in contrast to
the threonine and serine phosphorylation observed in immu-
noprecipitated p67phox (Fig. 3B). The immunoprecipitations
were carried out from neutrophil cytosol because the phos-
phorylation signal of the small amounts of p67phox at the
membrane is not intense enough to map by these methods.
We have previously shown that the strongest phosphopeptide
signal from cytosol-immunoprecipitated p67phox (signal (ii)) is
due to the phosphorylation of threonine-233 [20]. The phos-
phopeptide maps of p67phox con¢rmed that the phosphoryla-
tion by membranes was on a di¡erent site from threonine-233,
but that it may occur weakly in the intact cell (Fig. 3B and C,
signal (i)). Phosphotyrosine is known to be relatively labile in
the acid hydrolysis of a two-dimensional phosphoamino acid
analysis, making it harder to detect than phosphothreonine or
phosphoserine [27]. Therefore, this result may indicate that
only by in vitro phosphorylation with membranes was the
stoichiometry of the tyrosine phosphorylation su⁄cient for
detection by acid hydrolysis. It was found that a low tyrosine
phosphorylation could be detected in the p67phox immunopre-
cipitated from neutrophils using sensitive anti-phosphotyro-
sine antibodies.
Anti-phosphotyrosine antibodies were used to address the
issue of whether tyrosine phosphorylation of p67phox is asso-
ciated with the NADPH oxidase activity. Tyrosine phospho-
Fig. 2. Comparison of the in vitro phosphorylation of p67phox and
p47phox by neutrophil cytosol. A Coomassie-stained gel and autora-
diograph of the in vitro phosphorylation reactions of recombinant
p67phox and p47phox by unstimulated neutrophil cytosol. Background
phosphorylation is shown as cytosol alone.
Fig. 3. Phosphopeptide analysis of the isolated membrane and intact
cell phosphorylation of p67phox. 2-dimensional phosphopeptide maps
of (A) the in vitro phosphorylation of recombinant p67phox by unsti-
mulated neutrophil membranes, (B) neutrophil p67phox, immunopre-
cipitated from the cytosol of PMA-stimulated cells and (C) co-appli-
cation of duplicate samples as applied to A and B. Insets are
phosphoamino acid analyses, indicating the resolution of phospho-
serine (S), phosphothreonine (T) and phosphotyrosine (Y). Phospho-
peptide positions (i, ii, iii) are discussed in the text.
Fig. 4. Phosphotyrosine analysis of p67phox, immunoprecipitated
from neutrophils. (A) Anti-phosphotyrosine immunoblots of
7.5U105 cell eq cytosol and 4.5U107 cell eq membranes from unsti-
mulated, PMA- or fMLP-stimulated neutrophils. The blots were de-
veloped by the ECL method. (B) Quantitation of the amount of ty-
rosine phosphorylation by densitometric analysis of immunoblots of
p67phox immunoprecipitates from 7.5U107 cell eq cytosol and
7.5U108 cell eq membranes. The ratio of the phosphotyrosine signal
to the p67phox signal is normalised against that of unstimulated cells
which was assigned 1.00. The entire experiment was performed three
times, the error bars indicate S.D.
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rylation of multiple proteins is known to occur upon stimu-
lation of the NADPH oxidase [28,29]. Fig. 4A con¢rms that
this takes place in the cytosol and at the membranes. p67phox
was immunoprecipitated from cytosol and membrane frac-
tions of neutrophils and the phosphotyrosine signals were
quanti¢ed by densitometry of immunoblots (Fig. 4B). The
extent of tyrosine phosphorylation was normalised for the
amount of p67phox protein detected by subsequent blotting
against anti-p67phox antibody for the cytosol and membranes
separately. A very weak tyrosine phosphorylation was de-
tected in p67phox of unstimulated cells, with the membrane
p67phox showing a stronger phosphotyrosine signal than cyto-
solic p67phox. This would be consistent with the tyrosine phos-
phorylation occurring mostly at the membrane.
The observed increase in tyrosine phosphorylation of cyto-
solic p67phox upon stimulation of neutrophils with PMA, but
not by the membrane receptor-mediated agonist fMLP, is
probably indicative of PMA’s documented inhibition of tyro-
sine phosphatases [30] rather than up-regulation of a physio-
logically active tyrosine kinase. Immunoprecipitation of mem-
brane-localised p67phox showed a decrease in the extent of
tyrosine phosphorylation by approximately half, despite an
increase in the amount of p67phox at the membrane. There-
fore, the fraction of cytosolic p67phox that translocates to the
membrane upon stimulation is not tyrosine-phosphorylated,
suggesting that tyrosine phosphorylation is not a requirement
for the membrane localisation. As the strongest phosphoryla-
tion signal was from the small amount of p67phox at the mem-
brane in unstimulated cells, these results do not support a role
for the p67phox tyrosine phosphorylation in the NADPH ox-
idase activation.
We investigated whether a role for p47phox was implicated
in the phosphorylation of p67phox. Interaction between p67phox
and p47phox in the cytosol has been suggested as a control
mechanism in the activation of the NADPH oxidase [16]. It
has previously been reported that p47phox phosphorylation is
normal in the absence of p67phox [12,24,31,32], suggesting that
phosphorylation does not require an intermolecular complex
in the cytosol. We investigated whether the phosphorylation
of p67phox is similarly independent of p47phox. We have pre-
viously shown that the p67phox phosphorylation in B lympho-
cytes is virtually the same as in neutrophils, with only small
di¡erences in the minor phosphopeptide signals [20]. EBV-
transformed B-cell lines were used to compare normal cells
with p47phox de¢cient cells. The phosphopeptide map of
p67phox, that was immunoprecipitated from normal cells,
was the same as that from two p47phox de¢cient CGD patients
(Fig. 5). The B-cell lines were proven to be p47phox de¢cient
by immunoblotting the whole cytosol with an a⁄nity-puri¢ed
antibody against p47phox. Hence, the phosphorylation of
p67phox appears to be independent of p47phox.
In summary, the phosphorylation of p67phox is a more
subtle event than the multiple site phosphorylation of
p47phox. Although tyrosine phosphorylation of p67phox may
occur weakly in the cell, the predominant phosphorylation
that correlates with activation of the NADPH oxidase is
due to serine/threonine phosphorylation. This phosphoryla-
tion is una¡ected by p47phox and is cytosol-based rather
than occurring at the membrane. These data support the hy-
pothesis that phosphorylation of p67phox occurs in the cytosol,
followed by translocation to the membrane, where p67phox
assembles with p47phox and the £avocytochrome-based
NADPH oxidase complex.
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